You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
AstraZeneca
Medtronic
Moodys
Harvard Business School

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: enoxaparin sodium


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Enoxaparin sodium

CASRN: 679809-58-6

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
McKinsey
McKesson
Mallinckrodt